Iobenguane I-123

Generic name: Iobenguane I-123
Brand names: AdreView
Dosage form: intravenous solution (370 mBq/5 mL)
Drug class: Diagnostic radiopharmaceuticals

Usage of Iobenguane I-123

Iobenguane I-123 is in a group of drugs called diagnostic radiopharmaceuticals (RAY dee oh far ma SOO tik als). Iobenguane I-123 is a radioactive agent that allows images of specific organs in the body to be detected by a gamma camera.

Iobenguane I-123 is used to detect certain kinds of tumors.

Iobenguane I-123 is also used in people with congestive heart failure to assess the function of nerves that control the heart muscle. Iobenguane I-123 can detect nerve damage to help identify a patient's risk of death from heart failure.

Iobenguane I-123 may also be used for purposes not listed in this medication guide.

Iobenguane I-123 side effects

Get emergency medical help if you have signs of an allergic reaction: hives; difficult breathing; swelling of your face, lips, tongue, or throat.

Common side effects of iobenguane I-123 may include:

dizziness;

rash, itching;

flushing (warmth, redness, or tingly feeling);

headache; or

bleeding around your IV needle.

This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

Before taking Iobenguane I-123

You should not be treated with iobenguane I-123 if you are allergic to iobenguane or iobenguane sulfate.

Tell your doctor if you have ever had:

kidney disease;

a thyroid disorder;

Parkinson's disease or other neurologic disorder;

high blood pressure;

if you are dehydrated or unable to urinate; or

if you are allergic to iodine.

Older adults may need kidney function tests before receiving iobenguane I-123. Your kidney function may also need to be watched closely after you have received this medication.

It is not known whether iobenguane I-123 will harm an unborn baby. Tell your doctor if you are pregnant or plan to become pregnant. There is a potential risk of fetal exposure to radiation while using iobenguane I-123.

It is not known whether iobenguane I-123 passes into breast milk or if it could harm a nursing baby. You should not breastfeed for at least 6 days after receiving iobenguane I-123. If you use a breast pump during this time, throw out any milk you collect. Do not feed it to your baby.

Relate drugs

Warnings

Follow all directions on your medicine label and package. Tell each of your healthcare providers about all your medical conditions, allergies, and all medicines you use.

What other drugs will affect Iobenguane I-123

Some medicines can interfere with the quality of images produced by iobenguane I-123. Tell your doctor about all your current medicines and any you recently stopped using, especially:

an antidepressant such as amitriptyline, Bupropion, citalopram, desipramine, fluoxetine, imipramine, paroxetine, sertraline, Wellbutrin, Zoloft, Prozac, Celexa, and others;

blood pressure medication; or

cough, cold, or allergy medicine that contains a decongestant (phenylephrine or pseudoephedrine).

This list is not complete. Other drugs may interact with iobenguane I-123, including prescription and over-the-counter medicines, vitamins, and herbal products. Not all possible interactions are listed in this medication guide.

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.